Latest Antiplatelet drug Stories
- - FDA clears investigational new drug submission NASHVILLE, Tenn., Feb. 11, 2015 /PRNewswire/ -- Cumberland Pharmaceuticals Inc.
- RE-VERSE AD(TM) is being conducted in more than 35 countries with aim to enroll 250 patients RIDGEFIELD, Conn., Nov. 10, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
Emergency Department-Based Observational Study Aims to Fill Data Gaps in ACS Care Shrewsbury, NJ (PRWEB) October 27, 2014 The Hospital Quality Foundation
ZWOLLE, The Netherlands, June 12, 2014 /PRNewswire/ -- Randomized Evaluation of short-term DUal antiplatelet therapy in patients with acute coronary syndrome treated with
Rapid CYP2C19 Testing for Personalized Antiplatelet Therapy in 600-Patient Clinical Trial with Spartan Bioscience (PRWEB) March 18, 2014 Spartan Bioscience
DUBLIN, February 5, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/vgwhc9/new_oral) has announced the addition of the "Concise Analysis
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.